Numerous studies, mostly performed on mammalian cell cultures, have implicated the Gadd45 family of small acidic proteins in cell cycle control (arrest and/or engagement in the apoptotic pathway). We report here the cloning, detailled expression pattern and functional characterisation in embryonic development of Ol-Gadd45g, the Oryzias latipes ortholog of mammalian Gadd45g. Its expression pattern, notably in the developing brain (optic tectum) strongly suggests that it is involved in cell cycle exit. Gain-of-function experiments (through mRNA injection) slowed down early development, and produced embryos clearly reduced in size, while morpholino knockdowns resulted in small embryos over-sensitive to DNA damage (UV irradiation). We further demonstrated that, following Ol-Gadd45g overexpression, cells are proliferation-arrested before both G1/S and G2/M cell cycle checkpoints, while in the MO-Ol-Gadd45 loss-of-function experiments cells are engaged in apoptosis rather than prevented from proliferating. These results show that Ol-Gadd45g is likely to play an important role in coordinating cell fate decisions during neurogenesis; they also demonstrate that the medakafish is a promising model to analyse in vivo the developmental control of the cell cycle. q
Introduction
Tightly regulated cell proliferation, differentiation, and death (apoptosis) are crucial to ensure the development of properly proportioned organs (Conlon and Raff, 1999) . Nowhere is this requirement more important than in neural development, since the central nervous system (CNS) is, in bilaterians, the organ exhibiting the highest complexity, and the largest number of cell types. In the CNS of all studied species, the process of cell differentiation is coordinated with the timing of cell cycle exit, since different types of neurons and glia are generated at specific times in a sequentially conserved order (Cremisi et al., 2003; Hu and Easter, 1999; McConnell, 1995; Ohnuma et al., 2001 Ohnuma et al., , 2002 . At the molecular level, evidence is accumulating that these processes are linked by a handful of dual function factors: cell cycle regulators that influence neural cell fate, and inversely, determination/differentiation factors that regulate the cell cycle (Dyer and Cepko, 2000; Levine et al., 2000; Ohnuma et al., 2001; Cremisi et al., 2003; Ohnuma and Harris, 2003) .
We have identified the optic tectum (OT) of the medaka Oryzias latipes as a valuable model system to study these processes. Indeed, in this structure, neural development follows a stereotypical temporal and spatial order: differentiation begins in rostral domains, and, as neuronal cells are gradually added onto these initial clusters, the proliferative zone becomes progressively restricted to two horseshoe shaped domains at the OT caudal, lateral and medial margin (Nguyên et al., 1999) . We reported previously that genes controlling cell cycle exit are expressed at the border between the OT proliferation and the differentiation zones, i.e. in a clearly defined and easily identifiable arrest zone (Nguyên et al., 2001a) . To gain further insight into the network that links the cell cycle to various aspects of neurogenesis, we conducted whole-mount in situ hybridisation (WMISH) screen aimed at isolating cDNAs representing potential cell cycle regulators (Nguyên et al., 2001b) .
By using this approach, we found a cDNA encoding a small protein, Ol-Gadd45g,which is the O. latipes ortholog of the mammalian Gadd45g, a member of the Gadd45 family of growth-arrest and DNA-damage inducible genes. Gadd45g, also termed CR6 (cytokin response gene 6; Beadling et al., 1993) was originally identified as an immediate early response gene in T cells stimulated by interleukin-2, and belongs to a three-member family comprising also Gadd45a (Gadd45, Fornace et al., 1998) , and Gadd45b (MyD118, Vairapandi et al., 1996) . This gene family encodes for evolutionary conserved, small, acidic, nuclear proteins. Individual members of this family are differentially induced by a variety of environmental stresses and genotoxic agents during terminal differentiation, as well as by apoptotic cytokines. In recent years, evidence has emerged that the proteins encoded by these genes play similar but not identical roles in terminal differentiation and negative growth control, including growth suppression and apoptotic cell death (Azam et al., 2001; Zhang et al., 2001; Vairapandi et al., 2002) .
How Gadd45 proteins fulfill these roles is not completely understood. It has been shown that Gadd45g proteins interact with cell cycle regulators such as PCNA, the cyclindependent kinase inhibitor p21 (Azam et al., 2001) , and specifically interact with the Cdk1/CyclinB1 complex, but not with other cdk1/cyclin complexes (Vairapandi et al., 2002) . The p21-binding domain of Gadd45 also encodes a Cdc2-binding activity, further pointing these molecules out as 'cross-talkers' with other cell cycle regulators (Yang et al., 2000) . Additionally, stress-inducible Gadd45-like proteins mediate the activation of the stress-responsive MTK1/MEKK4 kinase (Takekawa and Saito, 1998) , an upstream activator of the p38/JNK kinase apoptotic pathway in response to environmental stresses as DNA damaging agents or anti-mitogenic cytokines.
This considerable wealth of data has been gathered, as is generally the case for this kind of regulatory molecules, by in vitro studies (biochemical and/or in mammalian cell cultures); in contrast, the data concerning the in vivo developmental function(s) of Gadd45 molecules appear rather sparse.
To determine whether Ol-Gadd45g plays a role in coordinating both cell cycle arrest/differentiation and cell death during development in the medaka embryo, we analysed the spatial and temporal patterns of Ol-Gadd45g expression and then evaluated the inhibitory effect on cell cycle progression by misexpression of Ol-Gadd45g in 2-cell stage embryos. Finally, we investigated the possible role of Ol-Gadd45g in proliferation and cell death in absence of environmental stresses, after Ol-Gadd45g loss-of-function by injection of an antisense morpholino.
Results

Cloning and sequence analysis
In the course of a WMISH screen (Nguyên et al., 2001b) , we have isolated the clone 30_22.6_F9 on the basis of its expression pattern, in the arrest zone between proliferative and post-mitotic domains. Nucleotide sequence analysis revealed that this clone corresponds to a cDNA of the Gadd45 family of growth-arrest-and-DNA-damageinduced genes. The Gadd45 gene family, composed of Gadd45a (Gadd45), Gadd45b (MyD118), and Gadd45g (CR6), encodes highly homologous small acidic proteins (55 -58% overall identity at the amino acid level) and are primarily nuclear (Azam et al., 2001 ). The evolutionary relationship among the members of this family was evaluated with the PHYLIP program and the resulting phylogenetic tree is shown in Fig. 1A . Further sequence alignments showed that clone 30_22.6_F9 encodes the O. latipes ortholog of the mammalian Gadd45g (Ol-Gadd45g). The full-length sequences of murine and human CR6/Gadd45g cDNAs have been determined (Takekawa and Saito, 1998; Zhang et al., 1999) and were observed to be 97% identical. A Xenopus Gadd45g has also been cloned (Calle-Mustienes et al., 2002) that is 78% identical to human Gadd45g. In other teleosts, a Gadd45g ortholog has not been described so far. Although Ol-Gadd45g protein resembles human Gadd45a and Gadd45b (51.5 and 55.6% identity, respectively), it is clearly more related to human and murine Gadd45g (60.6 -61.2% identity at the amino acid level). Multiple alignment of these proteins (Fig. 1B) shows several conserved domains among the members of this family.
Expression of Ol-Gadd45g
Expression of Ol-Gadd45g was analysed by WMISH in medaka embryos and on sections of hybridised embryos and adult brains. Ol-Gadd45g transcripts are not detected during early cleavage and gastrula stages. Ol-Gadd45g mRNA expression is first detected at stage 17 (early neurula stage; Fig. 2A ): strong signals are present around the blastopore at the caudal end of the body, in the tail-bud (see also Fig. 3A) , and at the rostralmost part of the brain anlagen. From stage 17 onwards, no Ol-Gadd45g mRNA expression can be detected outside of the CNS. In transverse sections through the medaka embryos at stage 20 (4-somite stage; Fig. 3B -G) , Ol-Gadd45g mRNA signal appears in several rows of cells of the ventral rhombencephalon ( Fig. 3C) as well in the dorsal part at the level of the isthmus (Fig. 3D ), that will form the cerebellar primordium. In the ventral mesencephalon, Ol-Gadd45g mRNA is also detected in several rows of cells (Fig. 3E) ; in the OT (dorsal mesencephalon), Ol-Gadd45g mRNA is detected in some scattered cells, in the area where the first signs of differentiation will appear (Nguyên et al., 1999) . Expression of Ol-Gadd45g is also present in the prosencephalon (Fig. 3F,G) . Additionally, Ol-Gadd45gmRNA expression is observed in the retina and the lens (Fig. 3F -G) . Ol-Gadd45g mRNA expression increases then throughout the brain (Fig. 2B -C) . At stage 26 (22 somites), Ol-Gadd45g mRNA expression is specially high within the rhombencephalon, which shows a characteristic mosaic pattern with labelled cells located at regular intervals along the transversal (Fig. 2B ) and longitudinal axis (Fig. 3H) . OlGadd45g mRNA expression is also detected in the olfactory bulbs from stage 26 onwards (Fig. 2B) . At stage 28 (onset of retina pigmentation; 30 somites), Ol-Gadd45g mRNA is highly expressed in most brain structures. In the rhombencephalon it shows the characteristic mosaic pattern described above (Fig. 2C ). In the caudal mesencephalon (Fig. 3J) , Ol-Gadd45g mRNA expression is present in nondifferentiated cells in the caudal OT (Nguyên et al., 1999) , while rostrally (Fig. 3K) , it is expressed at the limit between (Fig. 2D) , this transcript is expressed in the tectum in a crescent-shaped zone at the limit between the proliferative and post-mitotic zones: in the tectum Ol-Gadd45g mRNA expression spreads radially following a rostral-to-caudal and lateral-to-medial gradient, and remains absent from the proliferative zone, i.e. in the caudal, ventrolateral and dorsomedial margins. Ol-Gadd45g-labelled cells are observed also in the adult brain ( Fig.  3N -R) : at the caudal margin of the cerebellum (Fig. 3O) , in some cells located next to the proliferative zone of caudal, medial and lateroventral margins of the tectum (Fig. 3O,P) , in the hypothalamus (Fig. 3Q ) and in the telencephalon (Fig. 3R ), where they are close to the ventricular space.
Ectopic expression of Ol-Gadd45g causes cell cycle arrest
Overexpression of Gadd45g in various cell lines has shown that this gene is involved in negative growth control (reviewed in Hoffmeyer et al., 2001) . To analyse the possible role of Ol-Gadd45g in cell cycle arrest or cell death in vivo, we microinjected variable amounts of OlGadd45g mRNA into one blastomere of 2-cell stage embryos. RNA spreads uniformly between the two blastomeres because in medaka, as in zebrafish (Kimmel and Law, 1985) , the early cleavages (from the one-cell to the 16-cell stage) are partial, incompletely sepating blastomeres from the giant yolk cell. Embryos injected with a balanced salt solution (BSS) or with the enhanced green protein (EGFP) mRNA were used as control. GFP mRNA injected embryos visualised under a fluorescence microscope at 10 hours post-injection (hpi) showed that RNA was uniformly distributed among all blastomeres. After injection, embryos were incubated at 26 8C and cell cleavages were monitored from the 4-cell stage until stage 10 (early blastula stage; about 1000 cells). Ol-Gadd45g mRNA was injected at concentrations ranging from 0.2 to 1.5 mg/ml. Doses below 0.5 mg/ml had no effect on embryonic development (results not shown), while at high doses (1.5 mg/ml), 23% of the embryos died due to non-specific toxic effects. However, microinjection of 0.5 mg/ml induced developmental delay during early development: 2 h post-injection, the number of cells in Ol-Gadd45g mRNA-injected embryos was severely reduced when compared to BSS-injected embryos, which divided normally ( Fig. 4A -D ; 97%, n ¼ 206). Moreover, cells in mRNA-injected embryos were larger, indicating a reduction in the number of cleavages. BSS-injected and OlGadd45g-injected embryos were fixed at stage 9 (pre-early blastula stage), stained with the DNA-specific fluorochrome 4 0 ,6-diamino-2-phenylindole dihydrochloride (DAPI), and cells were counted. Ol-Gadd45g-injected embryos showed a decrease in cell number when compared to BSS-injected ones (233.2^56 versus 348^19). (N) ; expressing cells are detected in the caudal pole of both the cerebellum (arrowheads) and the optic tectum (arrow); (P) detail in a transverse section through the medial line of the optic tectum; (Q,R) transversal sections through the prosencephalon showing several labelled cells in the hypothalamus (Q), and in the telencephalon, close to the ventricular space (arrow in R). Cb, cerebellum; d, differentiation zone; e, eye; h, hypophysis; ha, habenula; Hy, hypothalamus; i, isthmus; L, lens; M, mesencephalon; OB, olfactory bulbs; OT, optic tectum; p, pineal organ; P, prosencephalon; pCb, primordium of the cerebellum; r, retina; Rh, rhombencephalon; Tel, telencephalon.
To examine whether Ol-Gadd45g could have an effect on cell death, 2-cell stage embryos injected with 0.5 mg/ml of Ol-Gadd45g mRNA were allowed to develop until stage 11 (late blastula, when apoptotic pathways become active; Hensey and Gauiter, 1997; Carter and Sible, 2003) and then stained with DAPI. This protocol has been widely used to identify chromatin condensation, nuclear shrinkage and formation of apoptotic bodies (Huynh and Teel, 2000; Zong et al., 2003) . While Ol-Gadd45g mRNA injected embryos had a reduced number of nuclei as compared to control ones (see above), no signs of apoptosis were observed (Fig. 4E-F) .
Ol-Gadd45g mRNA effects were dose-dependent: development was more severely affected in embryos injected with 0.8 mg/ml of Ol-Gadd45g mRNA (Table 1) . Although all Ol-Gadd45g mRNA injected embryos went through gastrulation, they were reduced in size, probably as a consequence of the early reduction in cell number ( Fig. 5A -C) . No effect on early cleavages nor later morphological changes were observed in embryos injected with similar amounts of GFP mRNA (Fig. 5D -F) .
Ectopic expression of Ol-Gadd45g modifies cell cycle pattern
To gain further insights into the roles that Ol-Gadd45 may play in the arrest of cell proliferation and cycle progression, mRNA injected embryos were analysed for DNA content by flow cytometry. Medaka embryos were staged before injection at the 2-cell stage, and allowed to develop at 26 8C until the 1000-cell stage (stage 10, early blastula), prior to the mid-blastula transition (MBT). We chose this developmental stage because early development before MBT is characterized by rapid and synchronous cell cycles (Yang et al., 2002) in which mitosis (M phase) occurs immediately after DNA replication (S phase), and thus, G1 or G2 interphases are not detectable; in this context, changes in the cell cycle pattern can be unequivocally detected. Suspensions of nuclei were prepared and stained with DAPI. Calibration (2N DNA content) was achieved by preparing suspensions of nuclei from adult medaka liver cells, which are G1 arrested (Fig. 6A) .
Histograms in Fig. 6B ,C represent the DNA content distribution of embryonic nuclear suspensions of uninjected (control) and Ol-Gadd45g mRNA-injected embryos. In absence of Ol-Gadd45g (Fig. 6B ), cells were either uniformly distributed between 2N and 4N (i.e. in S phase; 62.4%) or contained 4N DNA (corresponding to cells in G2 þ M phase; 35.8%). The percentage of cells in G1 was negligible (1.8%). Ol-Gadd45g clearly arrested the cell cycle progression at both G1 and G2/M (Fig. 6C) , since OlGadd45g mRNA injected embryos exhibited an increased percentage of cells in either G1 (24.9%) or G2 þ M (60%), and a decreased percentage in cells in S phase (15.1%). In addition, flow cytometry analysis showed no evidence of apoptosis in the nuclei of the injected embryos, which would have been manifested by a DNA content that is less than the G1 content. Taken together, these data suggest that Ol-Gadd45g affects cell proliferation and is a potent inhibitor of cell cleavage/division.
Increase in Ol-Gadd45g expression does not affect later development
The expression pattern of Ol-Gadd45g, as well as its interactions with a number of cell cycle regulators (Azam et al., 2001; Vairapandi et al., 2002; Yang et al., 2000) suggests that Ol-Gadd45g may play a role as a link between cell cycle exit and neuronal differentiation. To examine whether it was indeed the case, we analysed the effect of misexpressing Ol-Gadd45g mRNA on the expression of Ol-DeltaA, a neurogenic gene expressed exclusively in neuronal progenitors. In non-injected embryos, Ol-DeltaA expression is rapidly downregulated in the post-mitotic area of the tectum, so that from stage 30 onwards it becomes confined to a narrow area in the proliferative zone (Fig. 7A -C) . In this context, premature Ol-DeltaA downregulation might lead to a premature neuronal differentiation. To test this hypothesis, both BSS-injected and Ol-Gadd45g mRNA-injected embryos were allowed to develop until the 19-stage (30hpf) and the 31-stage (96hpf), and analysed for Ol-DeltaA expression by whole mount in situ hybridisation. When 0.5 mg/mlinjected embryos (Fig. 7E,H) , or 0.8 mg/ml-injected embryos (Fig. 7F,I ) were observed at 96 hpf, they showed an Ol-DeltaA expression pattern that was fairly identical to the pattern observed in uninjected embryos at stage 28 and 24, respectively (Fig. 7B,C) , corresponding to the above-described delay in development. However, misexpression of Ol-Gadd45g mRNA does not cause premature decrease of Ol-DeltaA expression, suggesting that cell cycle arrest is not sufficient to induce neuronal differentiation. Similar results were obtained when embryos were fixed and observed for Ol-DeltaA mRNA expression at 30 hpf (not shown). These observations further suggest that both reduced size and developmental delay in Ol-Gadd45g mRNA-injected embryos were a consequence of the early effect of this gene in cell cycle arrest rather than to premature neuronal differentiation.
Loss of function of Ol-Gadd45g
We further explored the effects of this gene on cell growth and viability by a loss of function approach using a morpholino antisense oligonucleotide (MO-Gadd45). Different doses (from 3 to 6 mg/ml) were injected in one blastomere of 2-cell stage embryos. As a control, we injected a morpholino containing 4-mispairs (MOGadd45-C). Injection of MO-Gadd45 had no visible effects during the gastrula stages, i.e. when Ol-Gadd45g is not expressed (not shown). From the early neurula-stage onwards several morphological abnormalities were detected in MO-Gadd45 injected embryos, including reduced size and developmental delay (Fig. 8) . Injection of the control MO (MO-Gadd45-C) at the same doses had no effect on medaka development. Additionally, the effect was clearly Table 1 . Similarly, embryo in (C) exemplifies the most frequent observed phenotype classified as severe in Table 1 . (D-F) When compared with uninjected embryos (D), injection of GFPmRNA alone at the indicated dose did not affect development (E); coinjection of Ol-Gadd45g mRNA and GFPmRNA (0.5 mg/ml each) causes developmental delay (F). Weak response: embryos show the diagnostic features corresponding to their developmental stage (as defined by Iwamatsu, 1994) , but they are reduced in size or present underdeveloped structures in the nervous system. Severe response: embryos lack the diagnostic features corresponding to their developmental stage.
dose-dependent since higher doses of MO-Gadd45 caused the strongest morphological abnormalities (see Table 2 ).
In order to characterise these effects further, MOinjected embryos were fixed 48 h post-injection and stained for the mitotic marker phospho-Histone H3 (pH3). While in control embryos mitotic cells appeared scattered throughout the brain (Fig. 9B) , in MO-Gadd45 injected embryos the distribution of pH3 þ cells became mostly restricted to the periventricular medial line (Fig. 9C,D) . Since these differences in distribution could be due to developmental delay, pH3 immunostaining in MOinjected embryos was compared to that of untreated embryos at stage 19 (2 somites; Fig. 9A ). pH3 pattern was found to be fairly similar between MO-injected and untreated younger embryos, indicating that the observed developmental delay might not primarily be due to altered cell proliferation.
Therefore, we determined whether this reduced size was due to an increase in cell death. With this aim, MO-injected embryos that had been previously stained for pH3 were then labelled for apoptosis by using the TUNEL assay. As shown in Fig. 9F -H, Ol-Gadd45g loss of function resulted in a strong increase in the number of apoptotic cells throughout the embryo. This high rate of cell death was never observed in younger untreated embryos (Fig. 9E) .
Since Gadd45 genes are known to be induced by UV irradiation, we examined whether Gadd45g loss of function could render embryos more sensitive to DNA damage. Embryos injected at the 2-cell stage with the MOGadd45 were allowed to develop until 11 hpf (pre-early gastrula stage), treated for 10 min with UV irradiation and incubated at 26 8C for 18 h (Gadd45 protein has been demonstrated to increase after 8 h and remain elevated for 48 h in cells UV irradiated; Maeda et al., 2003) . Embryos were then fixed and analysed for developmental abnormalities (see Table 3 ). While uninjected embryos develop almost normally from the pre-early gastrula stage to stage 19 (Fig. 10C) , MO-Gadd45 injected embryos showed severe abnormalities and delayed development (Fig. 10D) , suggesting that Ol-Gadd45g is necessary for allowing cell to DNA-damage-reparation and consequent cell survival.
Discussion
Understanding the molecular genetic pathways that mediate negative growth control is of high priority from both a basic science and cancer therapeutic point of views (Azam et al., 2001) . To gain insight into how the balance between proliferation, growth arrest and apoptosis can contribute to embryogenesis, we performed a large-scale screen by WMISH aimed at identifying genes differentially expressed in the regions in which cells stop dividing and begin differentiating, and that might therefore have a role in negative regulation of cell growth. In this study we show the cloning and characterisation of Ol-Gadd45g, a member of the Gadd45 family. This gene is involved in growth arrest, DNA damage repair, chromatin structure, apoptosis and signal transduction (Zhang et al., 1999; Campomenosi and Hall, 2000) . Moreover, these results open the route to the use of the medaka as an effective model system to study the specific effects of any new candidate molecule on regulating proliferation in vivo during development or in pathological outcomes at adulthood.
Ol-Gadd45g is expressed between the proliferation and the differentiation zone in the optic tectum of the medaka
In a previous study (Nguyên et al., 2001b) , we took advantage of the peculiar mode of growth of the medaka OT to identify genes that were differentially expressed in the region in which cells stop to divide and begin to differentiate, with the rationale that these molecules can be predicted to be negative regulators of cell cycle progression and cell growth. We report here the characterisation of one of these genes, the medaka homologue of the human and murine Gadd45g, a member of a family of growth arrest and DNA damage-activated genes .
In medaka embryonic brain, Ol-Gadd45g expression pattern is remarkably similar to that of other negative growth regulators, i.e. Ol-KIP, a medaka member of the CIP/KIP family of cyclin dependent kinase inhibitors (Nguyên et al., 2001a) , with prominent expression domains in the rhombencephalon, the arrest zone of the OT, the hypothalamus and the telencephalon. However, in the adult CNS, Ol-Gadd45g continues to be expressed exclusively in, or in close relation to, the mitotic domains (most notably the OT and the hypothalamic and telencephalic ventricules, Nguyen et al., 1999) . This is in clear contrast with Ol-KIP expression, which is turned on in many post-mitotic zones of the medaka adult CNS (Nguyên et al., 2001a) . It would be of interest to study systematically the expression of socalled 'cell cycle regulators' in the adult brain, as this can allow to propose hypotheses on their late functions.
Gadd45g affects cell cycle progression in medaka embryos
Evidence has accumulated that Gadd45 family members are important negative growth modulators Short-term transfection assays in several different human tumor cell lines have shown that the three members of the Gadd45 family can synergize in suppression of colony formation (Takekawa and Saito, 1998; Vairapandi et al., 1996 Vairapandi et al., , 2000 Zhang et al., 2002) . However, these events may reflect either inhibition of cellular proliferation, increased cell death, or both. By using diverse cell lines, it has been shown that inducible expression of the Gadd45 family members resulted in retardation of cellular proliferation and accumulation of cells in both G1 phase and G2 phase of the cycle (Smith et al., 1994; Fan et al., 1999; Zhang et al., 2001; Vairapandi et al., 2002) . However, whether Gadd45 plays a direct role in apoptosis remains controversial since exogenous Gadd45 can either induce DNA fragmentation in tumoral cell lines (Takekawa and Saito, 1998) or to cause G2 arrest but not apoptosis into human fibroblasts (Sheikh et al., 2000) .
Much less in known about the function of Gadd45 genes in embryonic development. We took advantage of the wellknown characteristics of the medaka embryo (total transparency, accessibility to injection, availability in high numbers) to analyse the effects of mis-expressing OlGadd45g in early development. Our results support the view n : Total number of injected embryos. a Phenotypic response to MO-Gadd45 injection at 44 hpf (%). Data shown is average of three ti five independent experiments per dose. Numbers in parentheses indicate the percentage of lethality. Fig. 9 . Loss of function of Ol-Gadd45g causes increased cell death without affecting proliferation. (A-D) Mitotic marker anti-pH3 in control embryos (A,B) or MO-Gadd45 injected embryos (C,D) at the indicated concentrations and developmental stages (in hpf). Embryos were injected at the 2-cell stage and analysed for proliferation at 48 hpf; the pattern of proliferation in embryos injected with both 3 mg/ml (C) and 5 mg/ml of MO-Gadd45 (D) is similar to that observed in younger uninjected embryos (compare to A, at 30 hpf). Control embryos (E,F) and MO-Gadd45 injected embryos (G,H) were then stained for apoptosis with TUNEL. Loss of function of Ol-Gadd45g highly increases the number of TUNEL þ cells (compare to uninjected younger embryos in E). that Ol-Gadd45g negatively regulates cell cycle progression, without engaging the cells in the apoptotic pathway. Indeed, flow cytometry analysis of DNA content shows that ectopic expression of Ol-Gadd45g mRNA causes cell cycle to arrest in both G1/S and G2/M phases with no evidence of apoptosis (Fig. 6) . This was further confirmed by closely examining DAPI-stained embryos before and around the MBT, where no apoptotic features were detected (Fig. 4) .
However, the molecular mechanism by which OlGadd45g exerts its effects in absence of DNA damage has not been elucidated. We observed strong effects of OlGadd45g on cell cycle arrest clearly before MBT, at a time in which zygotic transcription is minimal (Yang et al., 2002) . This suggests that Ol-Gadd45g regulates cell cycle molecules by direct protein-protein interaction. As a matter of fact, Gadd45g protein has been demonstrated to bind the cell cycle inhibitor p21 and the proliferating cell nuclear antigen (PCNA, a normal component of multiple quaternary complexes, including the cyclin CDKs and the CDK inhibitor p21), which plays a central role in DNA repair and DNA replication (Xiong et al., 1993; Harper et al., 1993; Smith et al., 1994; Hall et al., 1995; Kearsey et al., 1995; Vairapandi et al., 1996; Azam et al., 2001) . Additionally, Gadd45g proteins have been shown to specifically interact and modulate the activity of the G2-phase specific cdc2/ CyclinB1 complex (Vairapandi et al., 2002) , providing a mechanism for a Gadd45-mediated G2/M checkpoint.
We show that medaka embryos can fully recover from misexpression of Ol-Gadd45g. Indeed, they do not exhibit gross morphological defects apart from their reduced size and delayed development (Fig. 5) . Moreover, the expression of the neurogenic gene Ol-DeltaA remains fairly normal (albeit delayed) in injected embryos at 96 hpf (Fig. 7) , suggesting that no obvious perturbation in neurogenesis results from the massive early overexpression of Ol-Gadd45g. These results are similar to those obtained in Xenopus, where neither increase nor reduction of Xenopus-Gadd45g affects primary neurogenesis (Calle-Mustienes et al., 2002) . However, lack of altered neurogenic pathways at 96 hpf does not necessarily indicate that Gadd45 proteins have no effects on these events. Indeed, following RNA injections, it is likely that early produced proteins are no more present at these late stages. Although similar results were observed at 30 hpf (not shown), when Gadd45g protein may still be present, further studies are needed to examine that point. Using transgenesis, it could for example be determined if, and how, misexpression of Ol-Gadd45g at the time of neurogenesis affects the fate of neuronal progenitors. In this context, it has been shown that in Xenopus neither the increase nor the reduction of Xenopus-Gadd45g affects primary neurogenesis (Calle-Mustienes et al., 2002) .
It is clear that further functional interference analyses are needed to explore the possible requirement of Ol-Gadd45g to mediate particular neuronal or glial fates during neurogenesis.
Ol-Gadd45g protects cells against apoptosis
Mechanisms regulating negative growth control, including growth arrest and programmed cell death, must be elucidated to understand how alterations in the balance between proliferation, growth arrest and apoptosis can contribute to malignancy (Vairapandi et al., 1996) . In recent years, evidence has accumulated that Gadd45 proteins exhibit pleiotropic effects, including growth arrest, DNA damage repair, and control of genomic stability when they are induced following DNA damage and other environmental stresses (Hollander et al., 1999; Campomenosi and Hall, 2000; Sheikh et al., 2000) .
In this work, we examined, by a morpholino knock-down approach, whether embryos deficient in Ol-Gadd45g could develop normally in absence of DNA damage. Our results show that the inhibition of Ol-Gadd45g mRNA translation causes developmental abnormalities, including a clear reduction in size, that cannot be compensated by other cell cycle regulators or by other members of the Gadd45 family. It is noteworthy that, based on multiple alignments of Gadd45 family members in other species, only the first five amino acids are conserved (15 pair of bases). Since 4 mismatches are sufficient to avoid the knockdown of a given gene by a MO, the MO designed against the first 25 bases of the Gadd45g ORF was most likely not effective against the other members of the family. Assays with the mitotic marker pH3 and the TUNEL method for detection of apoptotic nuclei indicated that the reduced size of MOinjected embryos was due to an increase in cell death, rather than a decrease in cell proliferation. Furthermore, MOinjected embryos were much more sensitive to DNA damage (induced by UV irradiation) than control ones (Fig. 10) . This further supports the view that Gadd45 genes are important actors in the maintenance of DNA integrity.
In conclusion, the results presented here point OlGadd45g as an important component of the molecular pathway that coordinates cell cycle arrest vs. apoptosis decisions during vertebrate development. This conclusion is supported by three lines of evidence (i) Ol-Gadd45g is expressed in a restricted area where a number of distinct decisions must be taken, namely whether to divide, differentiate, or die; (ii) Ol-Gadd45g ectopic expression leads to cell cycle arrest in both G1/S and G2/M checkpoints, without inducing apoptosis, and (iii) Loss-offunction of Ol-Gadd45g proteins causes a significative increase in apoptosis, suggesting that in absence of OlGadd45g, cells impaired in G1 or G2 checkpoints might shift from DNA repair to programmed cell death.
In recent years, small fishes have emerged as undisputable models for the study of early vertebrate development (axis formation, gastrulation, patterning). We believe that their potential as model systems goes beyond these early developmental steps, and that the medaka embryo can be used as an 'in vivo test tube' to get insights on the developmental functions of so-called 'cell cycle regulators', nicely supplementing the vast amount of data gathered using mammalian cell cultures.
Experimental procedures
Fish strains and breeding conditions
Medaka embryos and adults of a Carbio strain (kindly provided by Jochen Wittbrodt, EMBL, Heidelberg, Germany) were used in all experiments Embryos were collected, incubated in Yamamoto's embryo rearing medium (Yamamoto, 1975) at 26 8C, and staged according to Iwamatsu (1994) .
RNA isolation and cDNA cloning of Ol-Gadd45g
Total RNA was extracted from the O. latipes anterior brain at stage 30 -31 using magnetobeads according to manufacturer's instructions (Dynal, Norway). Total RNA was reverse transcribed using oligo(dT) primers following SMART PCR cDNA Synthesis Kit instructions (Clontech, CA, USA). The library was ligated into pBSII/SK þ (Stratagene) and transformed into Escherichia coli XL1 Blue (Stratagene) as described in Nguyên et al., 2001b .
Synthesised cDNA was used as template for PCR amplification of the Ol-Gadd45g coding region, using the following primers: pRN3L.G45 g, 5 0 -CGGAATTCG-CGGGGACTGCTCTCTTGGACTAAA-3 0 ; pRN3R.G45 g, 5 0 -ATAGTTTAGCGGCCGCACCAAGGAAGCTCTG-CG-3 0 . A DNA fragment of , 600pb in size was isolated with QiaexII (Quiagen), subcloned into pCRII-TOPO (Invitrogen) and sequenced. This fragment was then excised with Eco RI and Not I, and cloned into pBluescript-RN3 (Lemaire et al., 1995) .
Custom synthesised oligonucleotides were from SigmaGenosys Ltd (UK) and DNA sequencing was performed by Genome Express (Meylan, France).
In situ hybridisation
Sense and antisense digoxigenin-UTP probes for Ol-Gadd45g and Ol-DeltaA were prepared according to Joly et al., 1997 . For WMISH, embryos were fixed overnight in 4% paraformaldehyde (PFA) in phosphate buffer 0.12 M (PB, pH 7.4). They were next mechanically dechorionated with fine forceps, dehydrated and stored at 2 20 8C in methanol. WMISH was performed with an Intavis automat. Proteinase K treatment was adapted to particular developmental stages according to Joly et al. (1997) , except for adult brains, in which proteinase K treatment was extended up to 45 min and detection up to 24 h. Control sense probes did not lead to any detectable signal. Whole embryos were mounted in 1% methylcellulose in tap water (Sigma, stored at 4 8C) and observed under a SV11 Zeiss dissecting microscope. For sectioning, stained and post-fixed embryos were paraffin embedded and microtome sectioned at 8 mm thickness. Pictures were taken with a Nikon DXM 1200 digital camera mounted on a Zeiss SV11 dissecting microscope.
Capped-mRNA synthesis and injection
DNA in pBluescript-RN3 was linearised with Not I, and transcribed in vitro with T3 RNA polymerase using the mMESSAGE mMACHINE kit (Ambion). Following DNAse treatment, RNA was purified with the RNeasy w Mini Kit (Qiagen).
For injection, mRNAs were resuspended in RNase free water. Medaka embryos were precisely staged before injection, and kept at 18 8C to slow development and thus allow time for microinjection of both Ol-Gadd45g mRNA and the different control solutions utilised in this study (BSS and EGFP mRNA, either alone or together with Ol-Gadd45g mRNA). Variable amounts of Ol-Gadd45g mRNA, ranging from 0.2 to 1.5 mg/ml, were injected into one blastomere at the 2-cell stage. At various stages (see text), the injected embryos were fixed for nuclear staining with DAPI or for WMISH.
Flow cytometric DNA content analysis
Ol-Gadd45g mRNA microinjected and control (uninjected) embryos were arrested simultaneously in liquid nitrogen at the early blastula stage (pre-MBT). Suspension of cells was achieved by dechorionation of embryos in Galbraith buffer 0.1% (MgCl2.6H 2 0 45 mM, Sodium citrate 30 mM, MOPS pH 7,0 20 mM, 0,1% Triton X-100) followed by gentle pipetting. Cell suspension was then filtrated through 50-mm nylon mesh and stained with 10 mg/ml 4 0 ,6-diamidino-2-phenylindole, dihydrochloride (DAPI). The stained nuclear suspension was analysed with a EPICS Elite ESP flow cytometer. In each experiment, an average of 3000 nuclei were analysed for each point.
Positive correlation between nuclear DNA content (fluorescence height) and particle size led to the identification of 2N and 4N DNA content populations. A suspension of nuclei prepared from adult medaka liver (prepared as described above) was used for calibration of the 2N DNA population. DNA histograms fit with a threecomponent model assuming that S-phase nuclei distribute equally between 2N and 4N DNA content, and that G1-phase nuclei and G2 þ M nuclei contribute to distributions around the 2N and the 4N DNA content respectively. DNA content histograms were resolved by the MultiCycle AV software.
Morpholino injection
The antisense morpholino oligonucleotide MO-Gadd45, 5 0 -GGATCGGAACCTCCTCGAAAGTCAT-3 0 (Gene Tools LLC) was diluted to 2.20 mM in RNase-free water, aliquoted and stored at 2 20 8C. The standard mispaired MO (MO-Gadd45-C, 5 0 -GCATCCGAACGTCGTCGAAAGT-CAT-3 0 ) was used as a control. For injection the stock solution was diluted to the adequate dose in basal salt solution (BSS).
Various amounts of MO (from 3 to 6 mg/ml) were injected into one blastomere at the 2-cell stage embryos. Embryos were fixed at different developmental stages and analysed for proliferation, cell death and resistence to UV treatment.
Histology and nuclei staining
Proliferation was analysed by whole-mount staining using an anti-phosphohistone H3 (Eurodiagnostica, 1:500) followed by biotinylated secondary antibody (VECTAS-TAIN Elite ABC kit, Vector LAboratories). An Avidin Biotinylated Horseradish Complex DAB was used for revelation.
Pre-early blastula (before MBT) and late blastula (after MBT) stage embryos were fixed for 2 h in 4% PFA and dechorionated. Blastoderm was then carefully separated from the yolk. Before MBT, cells were counted with the Metamorph w Imaging System software, following incubation with the DNA-specific and blue-emitting fluorochrome DAPI (300 nM in PBS for 30 min). After MBT, DAPI-stained cells were microscopically analysed for evidence of apoptosis. After neurulation, when DAPI cannot be used in toto, cell death was determined by whole-mount labelling of DNA strand breaks (TUNEL technology) by using the In situ Cell Death Detection Kit, AP (Roche Molecular Biochemicals). Embryos were permeabilised with 0.1% Triton X-100 in 0.1% sodium citrate. After incubation with the TUNEL-reaction mixture, embryos were analysed under a fluorescence microscope using a detection wavelength in the range of 515 -565 nm.
UV exposure
Both uninjected and MO-Gadd45 injected embryos (as described above) were allowed to develop until 11 hpf (stage 12, pre-early gastrula) and exposed to UV irradiation in a CN-TFX Darkroom UV generator (Fisher Bioblock Scientific), for 10 min, and a intensity of 8 mW/cm 2 . They were then incubated normally until 30hpf (stage 19; 2 somites), fixed and analysed for possible morphological alterations.
